NCT06783647 2026-02-12A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]Nanjing Leads Biolabs Co.,LtdPhase 2 Recruiting230 enrolled